Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Research progress of bile biomarkers and their immunoregulatory role in biliary tract cancers
Yuncheng Li, Kang-shuai Li, Zengli Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 13

Showing 13 citing articles:

Bile-Derived cfDNA of Syncytin-1 and SLC7A11 as a Potential Molecular Marker for Early Diagnosis of Cholangiocarcinoma
Jing He, Jingrong Qian, Xin Li, et al.
Journal of Gastrointestinal Cancer (2025) Vol. 56, Iss. 1
Open Access
Cholangiocarcinoma: The era of liquid biopsy
Evgenia Kotsifa, Francesca Saffioti, Vasileios Mavroeidis
World Journal of Gastroenterology (2025) Vol. 31, Iss. 11
Closed Access
Bile liquid biopsy in biliary tract cancer
Fusheng Liu, Xingyuan Hao, Bin Liu, et al.
Clinica Chimica Acta (2023) Vol. 551, pp. 117593-117593
Open Access | Times Cited: 11
Bile as a liquid biopsy matrix: potential applications and limitations
María Arechederra, María Rullán, Daniel Oyón, et al.
(2024), pp. 5-21
Open Access | Times Cited: 2
Clinical Application of Different Liquid Biopsy Components in Hepatocellular Carcinoma
Jing Xu, Yuanyuan Zhao, Zhishui Chen, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 4, pp. 420-420
Open Access | Times Cited: 2
Advances in omics-based biomarker discovery for biliary tract malignancy Diagnosis:A narrative review
Tao Xu, Lingna Lyu, Zheng Junfu, et al.
Molecular and Cellular Probes (2024) Vol. 76, pp. 101970-101970
Open Access | Times Cited: 2
MicroRNAs as Bile-based biomarkers in pancreaticobiliary cancers (MIRABILE): a cohort study
Daniel Liu, Jisce R. Puik, Morten T. Venø, et al.
International Journal of Surgery (2024) Vol. 110, Iss. 10, pp. 6518-6527
Open Access | Times Cited: 2
SMAD4 regulates the progression of cholangiocarcinoma by modulating the expression of STING1
Anda Shi, Liming Zhao, Guo‐li Sheng, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 17, pp. 2547-2561
Open Access | Times Cited: 3
Bile molecular landscape provides pathological insight and classifies signatures predictive of carcinoma of gall bladder.
Nupur Sharma, Sadam H. Bhat, Babu Mathew, et al.
Deleted Journal (2024) Vol. 32, Iss. 4, pp. 200904-200904
Open Access
Protocol of REACH-01: a single-arm, open label, prospective study of HAIC sequential TAE combined with tislelizumab and surufatinib in unresectable intrahepatic cholangiocarcinoma
Kangshuai Li, Yi Liu, Tingguo Zhang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Liquid Biopsy in Gallbladder Carcinoma: Current Evidence and Future Prospective
Sridhar Mishra, Swati Kumari, Nuzhat Husain
The Journal of Liquid Biopsy (2024) Vol. 6, pp. 100280-100280
Open Access
Comparison of clinicopathological characteristics and survival outcomes between gallbladder mucinous adenocarcinoma and gallbladder adenocarcinoma: A propensity score-matched study
Wenwei Yang, Yuting Fang, Ya-Ru Niu, et al.
World Journal of Gastrointestinal Oncology (2023) Vol. 15, Iss. 8, pp. 1436-1450
Open Access | Times Cited: 1
Development and validation of prognostic nomograms in patients with gallbladder mucinous adenocarcinoma: A population-based study
Xiao–Ming Xu, Jingzhi Wang
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 1
Page 1

Scroll to top